EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 / No 3 (Mars 2023) Med Sci (Paris), 39 3 (2023) 271-280 References
Free Access
Issue
Med Sci (Paris)
Volume 39, Number 3, Mars 2023
Néphrologie pédiatrique : de grandes avancées et un futur rempli d’espoir
Page(s) 271 - 280
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2023034
Published online 21 March 2023
  1. Wong CS, Gipson DS, Gillen DL, et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 2000 ; 36 : 811–819. [CrossRef] [PubMed] [Google Scholar]
  2. Harambat J, Bonthuis M, van Stralen KJ, et al. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol 2014 ; 9 : 92–99. [CrossRef] [PubMed] [Google Scholar]
  3. Franke D, Winkel S, Gellermann J, et al. Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol 2013 ; 28 : 2043–2051. [CrossRef] [PubMed] [Google Scholar]
  4. Behnisch R, Kirchner M, Anarat A, et al. Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study. Front Pediatr 2019 ; 7 : 278. [CrossRef] [PubMed] [Google Scholar]
  5. Fletcher HM. Infantilism with Polyuria and Chronic Renal Disease. Proc R Soc Med 1911 ; 4 : 95. [PubMed] [Google Scholar]
  6. Paterson DH. Three Cases of Renal Dwarfism associated with Curious Bony Changes. Proc R Soc Med 1920 ; 13 : 107–118. [PubMed] [Google Scholar]
  7. Broyer M. Growth hormone and delayed growth in the chronic renal insufficiency child. Nephrologie 1990 ; 11 : 247. [PubMed] [Google Scholar]
  8. Tonshoff B, Mehls O, Heinrich U, et al. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990 ; 116 : 561–566. [CrossRef] [PubMed] [Google Scholar]
  9. Greenbaum LA, Munoz A, Schneider MF, et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 2011 ; 6 : 14–21. [CrossRef] [PubMed] [Google Scholar]
  10. Ohlsson C, Bengtsson BA, Isaksson OG, et al. Growth hormone and bone. Endocr Rev 1998 ; 19 : 55–79. [PubMed] [Google Scholar]
  11. Brown DD, Dauber A. Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease. Horm Res Paediatr 2021; 94 : 105–14. [CrossRef] [PubMed] [Google Scholar]
  12. Hokken-Koelega AC, Hackeng WH, Stijnen T, et al. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J Clin Endocrinol Metab 1990 ; 71 : 688–695. [CrossRef] [PubMed] [Google Scholar]
  13. Hartung EA, Furth SL. Growth in children on renal replacement therapy: a shrinking problem?. Pediatr Nephrol 2013 ; 28 : 1905–1908. [CrossRef] [PubMed] [Google Scholar]
  14. Haffner D, Schaefer F, Girard J, et al. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 1994 ; 93 : 1163–1171. [CrossRef] [PubMed] [Google Scholar]
  15. Tonshoff B, Blum WF, Wingen AM, Mehls O. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Clin Endocrinol Metab 1995 ; 80 : 2684–2691. [PubMed] [Google Scholar]
  16. Giusti M, Perfumo F, Verrina E, et al. Biological activity of luteinizing hormone in uraemic children: spontaneous nocturnal secretion and changes after administration of exogenous pulsatile luteinizing hormone-releasing hormone-preliminary observations. Pediatr Nephrol 1991 ; 5 : 559–565. [CrossRef] [PubMed] [Google Scholar]
  17. Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009 : S1–130. [Google Scholar]
  18. Harambat J, Kunzmann K, Azukaitis K, et al. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease. Kidney Int 2017 ; 92 : 1507–1514. [CrossRef] [PubMed] [Google Scholar]
  19. Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr 2003 ; 13 : 149–152. [CrossRef] [PubMed] [Google Scholar]
  20. Drube J, Wan M, Bonthuis M, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 2019 ; 15 : 577–589. [CrossRef] [PubMed] [Google Scholar]
  21. Norman LJ, Coleman JE, Macdonald IA, et al. Nutrition and growth in relation to severity of renal disease in children. Pediatr Nephrol 2000 ; 15 : 259–265. [CrossRef] [PubMed] [Google Scholar]
  22. Ingulli EG, Mak RH. Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr 2014 ; 26 : 187–192. [CrossRef] [PubMed] [Google Scholar]
  23. Fine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease?. Pediatr Nephrol 2010 ; 25 : 739–746. [CrossRef] [PubMed] [Google Scholar]
  24. Al-Uzri A, Matheson M, Gipson DS, et al. The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr 2013 ; 163 : 736–41 e1. [CrossRef] [PubMed] [Google Scholar]
  25. Judge TA, Cable DM. The effect of physical height on workplace success and income: preliminary test of a theoretical model. J Appl Psychol 2004 ; 89 : 428–441. [CrossRef] [PubMed] [Google Scholar]
  26. Broyer M, Le Bihan C, Charbit M, et al. Long-term social outcome of children after kidney transplantation. Transplantation 2004 ; 77 : 1033–1037. [CrossRef] [PubMed] [Google Scholar]
  27. Seikaly MG, Waber P, Warady BA, Stablein D. The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry. Pediatr Nephrol 2009 ; 24 : 1711–1717. [CrossRef] [PubMed] [Google Scholar]
  28. Powell DR, Liu F, Baker BK, et al. Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 1997 ; 51 : 1970–1979. [CrossRef] [PubMed] [Google Scholar]
  29. Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2012 : CD003264. [PubMed] [Google Scholar]
  30. Hokken-Koelega A, Mulder P, De Jong R, et al. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 2000 ; 14 : 701–706. [CrossRef] [PubMed] [Google Scholar]
  31. Haffner D, Wuhl E, Schaefer F, et al. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J Am Soc Nephrol 1998 ; 9 : 1899–1907. [CrossRef] [PubMed] [Google Scholar]
  32. Fine RN, Kohaut E, Brown D, et al. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int 1996 ; 49 : 781–785. [CrossRef] [PubMed] [Google Scholar]
  33. Fischbach M, Terzic J, Menouer S, et al. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial Transplant 2010 ; 25 : 867–873. [CrossRef] [PubMed] [Google Scholar]
  34. Zhang H, Zheng Y, Liu L, et al. Steroid Avoidance or Withdrawal Regimens in Paediatric Kidney Transplantation: A Meta-Analysis of Randomised Controlled Trials. PLoS One 2016 ; 11 : e0146523. [CrossRef] [PubMed] [Google Scholar]
  35. Guest G, Berard E, Crosnier H, et al. Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 1998 ; 12 : 437–446. [CrossRef] [PubMed] [Google Scholar]
  36. Santos F, Moreno ML, Neto A, et al. Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Clin J Am Soc Nephrol 2010 ; 5 : 1190–1197. [CrossRef] [PubMed] [Google Scholar]
  37. Mencarelli F, Kiepe D, Leozappa G, et al. Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol 2009 ; 24 : 1039–1046. [CrossRef] [PubMed] [Google Scholar]
  38. Rees L, Azocar M, Borzych D, et al. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol 2011 ; 22 : 2303–2312. [CrossRef] [PubMed] [Google Scholar]
  39. Haffner D, Schaefer F, Nissel R, et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 2000 ; 343 : 923–930. [CrossRef] [PubMed] [Google Scholar]
  40. Hokken-Koelega AC, Stijnen T, de Ridder MA, et al. Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994 ; 343 : 1313–1317. [CrossRef] [PubMed] [Google Scholar]
  41. Gil S, Aziz M, Adragna M, et al. Near-adult height in male kidney transplant recipients started on growth hormone treatment in late puberty. Pediatr Nephrol 2018 ; 33 : 175–180. [CrossRef] [PubMed] [Google Scholar]
  42. Mahan JD, Warady BA, Consensus C. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 2006 ; 21 : 917–930. [CrossRef] [PubMed] [Google Scholar]
  43. Group KW. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 2009 ; 53 : S11–104. [Google Scholar]
  44. Lewis M, Shaw J, Reid C, et al. Growth in children with established renal failure–a Registry analysis (chapter 14). Nephrol Dial Transplant 2007; 22 : vii176–80. [PubMed] [Google Scholar]
  45. van Huis M, Bonthuis M, Sahpazova E, et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant 2016 ; 31 : 609–619. [CrossRef] [PubMed] [Google Scholar]
  46. Greenbaum LA, Hidalgo G, Chand D, et al. Obstacles to the prescribing of growth hormone in children with chronic kidney disease. Pediatr Nephrol 2008 ; 23 : 1531–1535. [CrossRef] [PubMed] [Google Scholar]
  47. Sempé M, Pédron G, Roy-Pernot MP. Auxologie méthode et séquences. Paris: Théraplix, 1979. [Google Scholar]
  48. Noto R, Maneatis T, Frane J, et al. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study. J Pediatr Endocrinol Metab 2011 ; 24 : 627–631. [CrossRef] [PubMed] [Google Scholar]
  49. Longmore DK, Conwell LS, Burke JR, et al. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients. Pediatr Transplant 2013 ; 17 : 731–736. [CrossRef] [PubMed] [Google Scholar]
  50. Nishi Y, Tanaka T. Growth Hormone Treatment and Adverse Events. Pediatr Endocrinol Rev 2017 ; 14 : 235–239. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.